Hermann Schulze
About Hermann Schulze
Hermann Schulze is the Senior Director of Regulatory Affairs at Sucampo Pharmaceuticals, Inc. with over two decades of experience in regulatory affairs and drug development.
Current Role at Sucampo Pharmaceuticals
Hermann Schulze is currently serving as the Senior Director of Regulatory Affairs at Sucampo Pharmaceuticals, Inc. in Rockville, Maryland, United States. Since joining the company in November 2012, he has been instrumental in the regulatory approval processes for drugs such as AMITIZA and RESCULA.
Previous Experience at Esbatech and Speedel Ltd
Hermann Schulze has a diverse background in regulatory affairs, having worked as the Head of Regulatory Affairs and Quality Assurance at Esbatech, a Novartis Company, from 2009 to 2012 in Schlieren, Zurich, Switzerland. Before that, he held the position of Head Drug Regulatory Affairs at Speedel Ltd for 7 months in 2008 and had served in the same company as Director Drug Regulatory Affairs from 2002 to 2006.
Roles at Pharmapart Ag and Ciba Vision
Between 2006 and 2008, Hermann Schulze was the Head of Regulatory Affairs at Pharmapart Ag. Prior to that, he worked for 4 years as the Drug Regulatory Affairs Manager at Ciba Vision in Duluth, Georgia, United States.
Early Career at Roche
Hermann Schulze spent a significant part of his early career at Roche, where he held multiple roles. He started with a Post-doc Fellowship from 1989 to 1991 in Switzerland. He then moved on to become the Drug Regulatory Affairs Manager from 1991 to 1998.
Educational Background
Hermann Schulze studied at Bielefeld University, providing him with a strong academic foundation that has supported his extensive professional career in regulatory affairs and drug development.